Qingdao Baheal Medical Inc
SZSE:301015
Income Statement
Earnings Waterfall
Qingdao Baheal Medical Inc
Revenue
|
7.5B
CNY
|
Cost of Revenue
|
-5.3B
CNY
|
Gross Profit
|
2.2B
CNY
|
Operating Expenses
|
-1.3B
CNY
|
Operating Income
|
883.7m
CNY
|
Other Expenses
|
-231.2m
CNY
|
Net Income
|
652.5m
CNY
|
Income Statement
Qingdao Baheal Medical Inc
Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||
Revenue |
5 879
N/A
|
6 538
+11%
|
6 797
+4%
|
7 038
+4%
|
7 052
+0%
|
7 286
+3%
|
7 436
+2%
|
7 336
-1%
|
7 510
+2%
|
7 336
-2%
|
7 414
+1%
|
7 486
+1%
|
|
Gross Profit | |||||||||||||
Cost of Revenue |
(4 415)
|
(4 897)
|
(5 133)
|
(5 218)
|
(5 277)
|
(5 420)
|
(5 516)
|
(5 405)
|
(5 426)
|
(5 276)
|
(5 282)
|
(5 308)
|
|
Gross Profit |
1 464
N/A
|
1 641
+12%
|
1 664
+1%
|
1 820
+9%
|
1 774
-2%
|
1 866
+5%
|
1 920
+3%
|
1 930
+1%
|
2 084
+8%
|
2 060
-1%
|
2 132
+3%
|
2 178
+2%
|
|
Operating Income | |||||||||||||
Operating Expenses |
(1 053)
|
(1 072)
|
(1 156)
|
(1 214)
|
(1 166)
|
(1 236)
|
(1 261)
|
(1 240)
|
(1 357)
|
(1 296)
|
(1 308)
|
(1 295)
|
|
Selling, General & Administrative |
(1 032)
|
(1 054)
|
(1 134)
|
(1 189)
|
(1 128)
|
(1 221)
|
(1 256)
|
(1 242)
|
(1 326)
|
(1 314)
|
(1 337)
|
(1 324)
|
|
Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(2)
|
(3)
|
(6)
|
(11)
|
(13)
|
|
Depreciation & Amortization |
(21)
|
(11)
|
(16)
|
0
|
(34)
|
0
|
0
|
0
|
(43)
|
0
|
0
|
0
|
|
Other Operating Expenses |
(0)
|
(7)
|
(6)
|
(25)
|
(4)
|
(15)
|
(5)
|
3
|
15
|
24
|
40
|
42
|
|
Operating Income |
411
N/A
|
569
+39%
|
507
-11%
|
606
+19%
|
608
+0%
|
630
+4%
|
659
+5%
|
690
+5%
|
726
+5%
|
764
+5%
|
824
+8%
|
884
+7%
|
|
Pre-Tax Income | |||||||||||||
Interest Income Expense |
(43)
|
(42)
|
(42)
|
(49)
|
(48)
|
(62)
|
(56)
|
(63)
|
(44)
|
(54)
|
(48)
|
(33)
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
(8)
|
1
|
0
|
0
|
|
Total Other Income |
3
|
2
|
4
|
13
|
4
|
5
|
6
|
(7)
|
(6)
|
(6)
|
(4)
|
(1)
|
|
Pre-Tax Income |
371
N/A
|
529
+43%
|
469
-11%
|
570
+22%
|
565
-1%
|
573
+1%
|
611
+7%
|
621
+2%
|
669
+8%
|
705
+5%
|
771
+9%
|
849
+10%
|
|
Net Income | |||||||||||||
Tax Provision |
(94)
|
(121)
|
(119)
|
(147)
|
(150)
|
(153)
|
(170)
|
(175)
|
(183)
|
(187)
|
(202)
|
(215)
|
|
Income from Continuing Operations |
277
|
408
|
350
|
423
|
415
|
420
|
440
|
446
|
485
|
517
|
569
|
634
|
|
Income to Minority Interest |
(5)
|
(5)
|
(2)
|
(2)
|
7
|
5
|
10
|
12
|
17
|
19
|
21
|
18
|
|
Net Income (Common) |
273
N/A
|
403
+48%
|
349
-14%
|
421
+21%
|
422
+0%
|
425
+1%
|
450
+6%
|
458
+2%
|
502
+10%
|
536
+7%
|
590
+10%
|
653
+11%
|
|
EPS (Diluted) |
0.52
N/A
|
0.76
+46%
|
0.83
+9%
|
0.8
-4%
|
0.85
+6%
|
0.8
-6%
|
0.86
+7%
|
0.87
+1%
|
0.96
+10%
|
1.02
+6%
|
1.12
+10%
|
1.24
+11%
|